$Cassava Sciences (SAVA.US)$ FDA has 150 to 180 days to make a decision on the Citizen Petition (CP) since it did not happen on 21 Jan the expectation is 22 Feb at the latest (180 days) as 20 Feb is Sunday and I understand 21st is a public holiday (President’s day). Rejection of the CP will obviously be positive for the stock price.

$Cassava Sciences (SAVA.US)$ too fast and furious triggered circuit breaker

$Cassava Sciences (SAVA.US)$ Trading resumes at 10am EST

$Cassava Sciences (SAVA.US)$ halted due to pending news

$Cassava Sciences (SAVA.US)$ a couple of additional news in the days ahead would really be awesome and intensify the grandma squeeze. eg: FDA rejection of CP followed by partnership

$Cassava Sciences (SAVA.US)$ In my opinion this SEC investigation may not be a bad thing, if the investigation proved no manipulation on the part of the company it will clear the claims by the skeptics. I have been following SAVA since it was a few dollars and I believe in the science that SAVA has demonstrated. To me this is like what happened to Tesla in the past, it depends on your research and conviction to decide whether to run for the exit or load up more on the dips, I am going for the latter. It’s ok to have difference in opinion as everyone’s financial position and risk appetite is different.

$Cassava Sciences (SAVA.US)$ One of the avenues the shorts take to push the price down for their own personal gains

$Cassava Sciences (SAVA.US)$ Vanguard Group loaded more SAVA

$Cassava Sciences (SAVA.US)$ H.C. Wainwright reiterated Buy rating on Cassava Sciences with $124 price target
https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-56